Literature DB >> 7930716

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.

E J McFarland1, P A Harding, D Luckey, B Conway, R K Young, D R Kuritzkes.   

Abstract

Circulating human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes (CTL) are seen less frequently in unstimulated peripheral blood mononuclear cells (PBMC) from children with vertically acquired HIV infection than in PBMC from HIV-infected adults. HIV-1 Gag-, reverse transcriptase (RT)-, and envelope (Env)-specific cytotoxic activity was studied in PBMC from HIV-infected children. Only 9% of subjects had Gag- or RT-specific CTL in unstimulated PBMC. However, in PBMC studied after CD3 stimulation, Gag- and Env-specific CTL were found in PBMC from 91% and 78% of HIV-infected children, respectively. Limiting dilution analysis of precursor CTL (pCTL) frequencies in PBMC from children > 12 months old demonstrated Gag- and Env-specific pCTL frequencies from 0.5 to 6.3/10,000 PBMC and from 0.66 to 33.0/10,000 PBMC, respectively. Thus, children with vertically acquired HIV infection have high frequencies of HIV-specific pCTL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930716     DOI: 10.1093/infdis/170.4.766

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines.

Authors:  Jie Zhang; Nicole Silvestri; J Lindsay Whitton; Daniel E Hassett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

3.  Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.

Authors:  L Kuhn; S Meddows-Taylor; G Gray; D Trabattoni; M Clerici; G M Shearer; C Tiemessen
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.

Authors:  Florence Buseyne; Daniel Scott-Algara; Françoise Porrot; Béatrice Corre; Nassima Bellal; Marianne Burgard; Christine Rouzioux; Stéphane Blanche; Yves Rivière
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.

Authors:  K Luzuriaga; M McManus; M Catalina; S Mayack; M Sharkey; M Stevenson; J L Sullivan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya.

Authors:  A Y Liu; B Lohman-Payne; M H Chung; J Kiarie; J Kinuthia; J Slyker; B Richardson; D Lehman; C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2015-04-20       Impact factor: 4.330

7.  Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.

Authors:  Sihong Huang; Jacqueline Dunkley-Thompson; Yanhua Tang; Eric A Macklin; Julianne Steel-Duncan; Indira Singh-Minott; Elizabeth G Ryland; Monica Smikle; Bruce D Walker; Celia D C Christie; Margaret E Feeney
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.

Authors:  M E Feeney; K A Roosevelt; Y Tang; K J Pfafferott; K McIntosh; S K Burchett; C Mao; B D Walker; P J R Goulder
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.

Authors:  Fatema A Legrand; Douglas F Nixon; Christopher P Loo; Erika Ono; Joan M Chapman; Maristela Miyamoto; Ricardo S Diaz; Amélia M N Santos; Regina C M Succi; Jacob Abadi; Michael G Rosenberg; Maria Isabel de Moraes-Pinto; Esper G Kallas
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.

Authors:  C A Pikora; J L Sullivan; D Panicali; K Luzuriaga
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.